Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites.
about
Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine AThe importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status.Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease.Host response tests for diagnosing periodontal diseases.Comparative analysis of gingival crevicular fluid β-glucuronidase levels in health, chronic gingivitis and chronic periodontitis.The relationship between periodontal status and alkaline phosphatase levels in gingival crevicular fluid in men with hypergonadotropic hypogonadism.Level of Oxidative Stress Markers in Peri-Implant Crevicular Fluid and Their Correlation with Clinical Parameters.Clinical and technical considerations in the analysis of gingival crevicular fluid.Effect of periodontal therapy on crevicular fluid interleukin-6 and interleukin-8 levels in chronic periodontitis.Association between interleukin-8 levels and chronic periodontal disease: A PRISMA-compliant systematic review and meta-analysis.Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population.Gingival crevicular fluid matrix metalloproteinase-25 and -26 levels in periodontal disease.Detection of stable and active periodontitis sites by clinical assessment and gingival crevicular acute-phase protein levels.The Effect of Nonsurgical Periodontal Therapy on HNP1-3 Level in Gingival Crevicular Fluid of Chronic Periodontitis Patients.Histology of the periodontal lesion: implications for diagnosis.Diagnosis of periodontal disease based on analysis of the host response.Comparison of Salivary Beta Glucuronidase Activity in Chronic Periodontitis Patients with and without Diabetes Mellitus.Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy.Estimation of salivary β-glucuronidase activity as a marker of periodontal disease: A case control study.Clinical findings and gingival crevicular fluid prostaglandin E2 and interleukin-1-beta levels following initial periodontal treatment and short-term meloxicam administration.Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers.Evaluation of transforming growth factor-beta 1 level in crevicular fluid of cyclosporin A-treated patients.Levels of leukotriene B4 in gingival crevicular fluid and gingival tissue in specific periodontal diseases.Mapping biological to clinical phenotypes during the development (21 days) and resolution (21 days) of experimental gingivitis.Five parameters of gingival crevicular fluid from eight surfaces in periodontal health and disease.Levels of interleukin-37 in gingival crevicular fluid, saliva, or plasma in periodontal disease.Tumor necrosis factor-alpha levels after surgical anti-infective mechanical therapy for peri-implantitis: a 12-month follow-up.Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A.Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis.Osteoprotegerin levels in peri-implant crevicular fluid.Increased levels of interleukin-33 in gingival crevicular fluids of patients with chronic periodontitis.Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in patients with aggressive periodontitis.Sulfate-reducing bacteria in the periodontal pocket.Antioxidant Micronutrients and Oxidative Stress Biomarkers.Cytokine (interleukin-1beta) and MMP levels in gingival crevicular fluid after use of platelet-rich fibrin or connective tissue graft in the treatment of localized gingival recessions.Monitoring bone morphogenetic protein-2 and -7, soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin levels in the peri-implant sulcular fluid during the osseointegration of hydrophilic-modified sandblasted acid-etched and sandGingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes.Acute-phase proteins in gingival crevicular fluid during experimentally induced gingivitis.Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes.
P2860
Q28371932-397E0E48-8D44-4882-9A27-C3E898EA0F1AQ30592231-7A30BEC7-FAB3-478E-8658-2F99D3098D2CQ34521101-A506E632-AD3B-4F31-A572-E5DD11CAD954Q35084032-D093FCFD-DE34-4476-952B-F1613BEE7B0DQ36056630-CD224A80-52EC-4BB8-8C8A-555C59CB9596Q36164119-03710820-B01E-4C04-9E88-B618FA014105Q37040820-41A617A7-CF72-4282-8B46-3EAF579D17A3Q38349979-6656381F-02BE-44A8-BBC7-1DE00D11E41EQ38667957-8B88B0FB-5336-4183-A282-8D11945AECDFQ38896849-5D194C2B-44AA-4175-A430-8DBA15FD4323Q39341077-92069F08-86C8-48BB-B9BE-DA69AD887362Q40288771-A35230F7-E64A-445B-993B-F9AEBD3D12C3Q40337096-E18453AC-93DA-4C38-BC2B-E3F16A556B97Q40951243-04E2E3D2-9753-4631-AC49-0AE216EF172FQ41020494-C88A8FCD-3F54-4CB7-8727-8519CBD0F295Q41754702-3DACA1B9-6F4F-423F-9566-EA39D414664CQ41754734-3F1E0E0E-384C-4F43-8EF3-7242CF3ED6CDQ41839626-7C7F27CA-FEBF-4964-94C9-F375DFF0AE3BQ42017463-9AC379C7-A2D4-49ED-B39B-39CCAC90DA31Q42120288-82DBC930-8CB4-4C51-AC8C-9EAAA27B7ADAQ43046416-DAD47BB8-861D-42D9-BFED-135613638A7AQ43135429-5B9A22CF-CA07-4FE4-A666-20381B418513Q43598371-74950002-AEA3-4F7A-B72A-DABD1F2CA8F8Q43721767-3488A051-FC26-418F-89DC-E08625AE33E9Q44635182-16D7FF7F-6F44-47B5-BE3F-692EEF3BD956Q45233315-1DBB4643-627B-49A2-A6E5-C8C2F84ACD28Q45946213-D14BE94F-CF5E-42FB-81F4-0084B66FC296Q46067295-6FA13236-86B3-4941-9E21-167DDFF65BADQ47676795-E2B5B452-47F7-4AC5-B64A-526C9626A207Q47681957-94B93A71-5CE5-4BA7-A214-8757F050EF84Q48024979-9C0F4BA0-8BA4-4791-BDD4-F79068907382Q48179583-9D45BF44-4FBB-4BAC-9925-5B457F7D7AF0Q48201575-EE14F63B-7313-4FA1-B037-E5E2165FB653Q51037446-B185BE4E-E87C-49A1-B639-91D883E6A912Q51281919-1A336426-84DA-4591-A01B-A1E24E0B51CBQ53323476-FED7ADD1-52D7-4B9C-8531-88B3F3F2628DQ53583069-8B49740D-B19D-4B7D-B962-773F01ACCC4BQ54158942-DF7843E2-61C4-4A12-A642-2E00151B7917Q54319129-09970317-AD8E-46E8-A632-4985843FA7F9Q54447152-3E156E77-D87C-4DDD-ABE1-33DEDF357254
P2860
Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Enzyme activity in human gingi ...... f individual crevicular sites.
@ast
Enzyme activity in human gingi ...... f individual crevicular sites.
@en
type
label
Enzyme activity in human gingi ...... f individual crevicular sites.
@ast
Enzyme activity in human gingi ...... f individual crevicular sites.
@en
prefLabel
Enzyme activity in human gingi ...... f individual crevicular sites.
@ast
Enzyme activity in human gingi ...... f individual crevicular sites.
@en
P2093
P2860
P1476
Enzyme activity in human gingi ...... f individual crevicular sites.
@en
P2093
P2860
P304
P356
10.1111/J.1600-051X.1986.TB00885.X
P407
P577
1986-09-01T00:00:00Z